{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:15:25Z","timestamp":1792304125221,"version":"4.4.0"},"reference-count":50,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2007,4,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The objective is to update previous meta-analyses with a systematic review of randomized palliative radiotherapy (RT) trials comparing single fractions (SFs) versus multiple fractions (MFs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The analysis includes all published reports from randomized trials comparing SF or MF schedules for the treatment of painful bone metastases with localized RT. A systematic review was performed using the random-effects model with Review Manager version 4.1 (Cochrane Collaboration, Oxford, UK). The odds ratio and 95% CI were calculated for each trial and presented in a forest plot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 16 randomized trials from 1986 onward were identified. For intention-to-treat patients, the overall response (OR) rates for pain were similar for SF at 1,468 (58%) of 2,513 patients and MF RT at 1,466 (59%) of 2,487 patients. The complete response (CR) rates for pain were 23% (545 of 2,375 patients) for SF and 24% (558 of 2,351 patients) for MF RT. No significant differences were found in response rates. Trends showing an increased risk for SF RT arm patients in terms of pathological fractures and spinal cord compressions were observed, but neither were statistically significant (P = .75 and P = .13, respectively). The likelihood of re-treatment was 2.5-fold higher (95% CI, 1.76 to 3.56) in SF RT arm patients (P &lt; .00001). Repeated analysis of these end points, excluding dropout patients, did not alter the conclusions. Generally, no significant differences with respect to acute toxicities were observed between the arms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No significant differences in the arms were observed for overall and CR rates in both intention-to-treat and assessable patients. However, a significantly higher re-treatment rate with SFs was evident.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2006.09.5281","type":"journal-article","created":{"date-parts":[[2007,4,6]],"date-time":"2007-04-06T18:20:42Z","timestamp":1175883642000},"page":"1423-1436","source":"Crossref","is-referenced-by-count":750,"title":["Palliative Radiotherapy Trials for Bone Metastases: A Systematic Review"],"prefix":"10.1200","volume":"25","author":[{"given":"Edward","family":"Chow","sequence":"first","affiliation":[{"name":"From the Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Harris","sequence":"additional","affiliation":[{"name":"From the Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Fan","sequence":"additional","affiliation":[{"name":"From the Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Tsao","sequence":"additional","affiliation":[{"name":"From the Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai M.","family":"Sze","sequence":"additional","affiliation":[{"name":"From the Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00510-0"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)04147-0"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(03)00113-4"},{"key":"R5","unstructured":"Sarkar SK, Sarkar S, Pahari B, et al: Multiple and single fraction palliative radiotherapy in bone secondaries: A prospective study. Ind J Radiol Imag 12:281,2002-284,"},{"key":"R6","unstructured":"Altunda\u011f MB, \u00dc\u00e7er AR, \u00c7aliko\u011flu T, et al: Single (500 cGy, 800 cGy) and multifraction (300 X 10 cGy) radiotherapy schedules in the treatment of painful bone metastases. Turkish Journal of Hematology-Oncology 12:16,2002-21,"},{"key":"R7","unstructured":"Badzio A, Senkus-Konefka E, Jereczek-Fossa BA, et al: 20 Gy in five fractions versus 8 Gy in one fraction in palliative radiotherapy of bone metastases. A multicentre randomized study. Journal of Oncology 53:261,2003-264,"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji139"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.09.017"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.05.006"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Haddad P, Behrouzi H, Amouzegar-Hashemi F, et al: Single versus multiple fractions of palliative radiotherapy for bone metastases: A randomized clinical trial in Iranian patients. Radiother Oncol 80:S65,2006,  (abstr 223)","DOI":"10.1016\/S0167-8140(06)80964-3"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(99)00110-3"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.10.006"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(97)00101-1"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(99)00097-3"},{"key":"R16","unstructured":"Foro P, Algara M, Reig A, et al: Randomized prospective trial comparing three schedules of palliative radiotherapy: Preliminary results. Oncologia 21:55,1998-60,"},{"key":"R17","unstructured":"Ozsaran Z, Yalman D, Anacek Y, et al: Palliative radiotherapy in bone metastases: Results of a randomized trial comparing three fractionation schedules. Journal of BUON 6:43,2001-48,"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(86)80191-8"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(89)80035-4"},{"key":"R20","unstructured":"Kagei K, Suzuki K, Shirato H, et al: A randomized trial of single and multifraction radiation therapy for bone metastasis: A preliminary report. Gan No Rinsho 36:2553,1990-2558,"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(98)00011-5"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1007\/s000660050061"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Kirkbride P, Warde P, Panzarella A, et al: A randomized trial comparing the efficacy of single fraction radiation therapy plus ondansetron with fractionated radiation therapy in the palliation of skeletal metastases. Int J Radiat Oncol Biol Phys 48:185,2000,  (suppl 3)","DOI":"10.1016\/S0360-3016(00)80164-9"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(88)90405-1"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(89)80010-X"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(89)80036-6"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(91)90062-L"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90568-3"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(05)80855-6"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1673.1995.tb00228.x"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00927-9"},{"key":"R32","unstructured":"Hartsell WF, Shah AB, Graney M, et al: Palliation of bone metastases in the USA: A survey of patterns of practice. Support Care Cancer 6:175,1998,"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)00238-3"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)00215-2"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)00250-4"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1080\/02841860310011131"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20706"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2005.10.002"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)00244-9"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(98)00105-4"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20993"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440060089011"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)02588-3"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850401)55:7<1468::AID-CNCR2820550708>3.0.CO;2-M"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(02)00170-6"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.3816\/SCT.2004.n.009"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.3.222"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji166"},{"key":"R50","unstructured":"Chow E, Coia L, Wu J, et al: This house believes that multiple-fraction radiotherapy is a barrier to referral for palliative radiotherapy for bone metastases. Current Oncology 9:60,2002-66,"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-4-71"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.09.5281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T16:06:12Z","timestamp":1653494772000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.09.5281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,10]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,4,10]]}},"alternative-id":["10.1200\/JCO.2006.09.5281"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.09.5281","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,10]]}}}